Roger Hartl, M.D.

Photos

525 E 68th St # 651
New York, NY 10065
Roger Härtl, M.D., is the Hansen-MacDonald Professor of Neurological Surgery and Director of Spinal Surgery at Weill Cornell Medicine, as well as Neurosurgical Director, Och Spine at NewYork-Presbyterian/Weill Cornell Medical Center. He is also the founder and director of Och Spine at NewYork-Presbyterian at the Weill Cornell Medicine Center for Comprehensive Spine Care as well as Weill Cornell Medicine's Global Neurosurgery Initiative in Tanzania (for which he was named AANS Humanitarian of the Year for 2022). He also serves as the official neurosurgeon for the New York Giants Football Team. IN THE NEWS:Dr. Härtl Named One of America's Top Spine SurgeonsDr. Härtl Selected to New York SuperDoctors 2024Dr. Härtl Named to Castle Connolly's 2024 List of Top DoctorsDr. Härtl's clinical interest focuses on simple and complex spine surgery for degenerative conditions, tumors and trauma as well as biological approaches for disc repair and regeneration. He is a world-renowned pioneer and leader in minimally invasive spinal surgery and computer-assisted spinal navigation surgery. He is actively involved in improving neurosurgical care in developing countries as the leader of Weill Cornell Medicine's Global Health Neurosurgery Initiative in Tanzania.In order to achieve the very best in patient outcomes, Dr. Härtl's practice emphasizes an interdisciplinary approach to disease processes and he works very closely with other specialists such as neurologists, pain specialists, sports medicine doctors and physical therapists. His patients come from all over the globe and include many physicians, surgeons and even other neurological and spine surgeons. He has been repeatedly named to the lists of New York Super Doctors, America's Top Surgeons, and America's Best Doctors, and has been included on the list of New York’s Best Doctors in New York magazine. He has authored more than 200 scholarly articles in peer-reviewed journals and is the editor of two books on minimally invasive spinal surgery and biological disc repair and regeneration.Dr. Härtl has provided commentary for numerous television shows on ABC, NBC, and CBS in addition to national radio shows. His expertise has been sought through interviews in the New York Times, The New York Post, The New York Daily News, and other media outlets. One of his patients, boxer Danny Jacobs, was recently featured in a TV ad from NewYork-Presbyterian.TRAINING Dr. Härtl received his M.D. from the Ludwig-Maximillians University in Munich, Germany. In 1994 Dr. Härtl came to the Weill Cornell Medical College as a post-doctoral research fellow in the Department of Surgery and the Brain Trauma Foundation to pursue research in traumatic brain and spinal cord injury. He completed another fellowship in neurocritical care at the Charite Hospital of the Humboldt University in Berlin, Germany, followed by a surgical internship and residency at Allegheny General Hospital in Pittsburgh, Pennsylvania. He completed his neurosurgery residency at NewYork-Presbyterian/Weill Cornell Medical Center and Memorial Sloan-Kettering Cancer Center, after which he pursued specialized training in complex spine surgery at the Barrow's Neurological Institute in Phoenix under Dr. Volker Sonntag. In 2004 Dr. Härtl returned to re-join the Department of Neurosurgery at Weill Cornell Medical College.RESEARCHDr. Härtl's scientific interest focuses on clinical and basic science research surrounding innovative and less invasive surgical and biological treatment strategies for degenerative diseases of the spine. Together with the Biomedical Engineering Department at Cornell he is working on tissue-engineering techniques for the repair and regeneration of degenerated spinal discs, the most common cause of back and neck pain. Dr. Härtl has lectured and published extensively on the surgical treatment of spinal disorders, and neurotrauma. He is a leader in the application of evidence-based medicine to neurosurgery and worked with the Brain Trauma Foundation in New York on the development of treatment guidelines for the medical and surgical management of head injury that are now used worldwide.~~~Dr. Härtl sees patients at the Och Spine at NewYork-Presbyterian at the Weill Cornell Medicine Center for Comprehensive Spine Care, at 240 East 59th Street, 2nd Floor.~~~FOR MORE INFORMATION:Please visit comprehensivespine.weillcornell.org for more information about conditions we treat and procedures we perform.
Owner verified
See a problem?

You might also like

Fangfei Zheng, M.D.
Internal medicine practitioners

Fangfei Zheng, M.D.

Dr. Saya Segal is a urogynecologist who specializes in the care of women with pelvic floor weakness resulting in conditions such as pelvic organ prolapse and bladder dysfunction. The network of pelvic structures which normally support a woman's uterus, bladder and rectum may weaken with progressing age, childbirth, obesity and other factors resulting in conditions such as cystocele, rectocele, uterine prolapse, urinary and fecal incontinence, bladder dysfunction and defecatory dysfunction.Dr. Segal offers comprehensive care for women with the above conditions. Together with the Weill Cornell Medicine physicians in the Division of Urogynecology in Obstetrics and Gynecology, Dr. Segal's patient treatment modalities include robotic, abdominal, and vaginal reconstructive surgery as well as medical and surgical treatment for urinary incontinence that span across a range of clinical options from guided pelvic muscle exercise to surgery for stress and/or urgency urinary incontinence. She also offers conservative management treatment options, such as in- office treatment for overactive bladder, and in office diagnostic procedures, like urodynamics and cystoscopy.Dr. Segal, who is trained as both a physician and an epidemiologist, has conducted extensive research aimed at improving outcomes for women with urogynecology issues. She has studied pelvic floor disorders in women across the age spectrum, and compared the outcomes of surgical versus conservative treatments for pelvic floor disorders.Dr. Segal is board certified in Obstetrics and Gynecology and Female Pelvic Medicine and Reconstructive Surgery. She received her undergraduate degree from the University of Texas at Austin, a Masters of Science in Clinical Epidemiology from the University of Pennsylvania, and her medical degree from the University of Texas Southwestern Medical School. After completing Obstetrics and Gynecology residency at New York University Medical Center, she completed an accredited three year fellowship in Urogynecology and Female Pelvic Medicine and Reconstructive Surgery at the University of Pennsylvania. Dr. Segal joined NewYork-Presbyterian, Weill Cornell Medicine in 2017 as an Assistant Professor of Obstetrics and Gynecology. Prior to joining Weill Cornell Medicine, Dr. Segal worked in the Division of Female Pelvic Medicine and Reconstructive Surgery at Rutgers-Robert Wood Johnson Medical School.
Jordan R. Stern, M.D.
Internal medicine practitioners

Jordan R. Stern, M.D.

Jordan R. Stern, MD, FACS is an Associate Professor of Surgery in the Division of Vascular and Endovascular Surgery at Weill Cornell Medicine, and an Associate Attending Surgeon at New York-Presbyterian/Weill Cornell Medicine. He maintains a robust clinical practice encompassing the full spectrum of vascular surgery including aortic aneurysms and dissections, peripheral arterial disease, carotid artery disease, and deep venous obstructive disease.Dr. Stern graduated with honors from the University of Western Ontario with a Bachelor of Medical Sciences in Biochemistry. He then earned his medical degree from The Ohio State University College of Medicine. Following this, he completed his General Surgery residency at The University of Chicago, which included a two-year research fellowship in Translational Systems Biology. He then completed his clinical fellowship in Vascular and Endovascular Surgery at New York-Presbyterian Hospital, Weill Cornell Medicine/Columbia University Medical Center. Dr. Stern is board certified in both General Surgery and Vascular Surgery. Prior to joining Weill Cornell Medicine, Dr. Stern was an Associate Professor of Surgery at Stanford University where he was on faculty for over 6 years.Dr. Stern has published more than 100 peer-reviewed scientific articles, book chapters, editorials, and abstracts, with a primary academic interest in the treatment of aortic disease. He has developed and described several novel treatment strategies for complex aortic pathologies and has served as principal or co-investigator on multiple industry-sponsored device trials. He also serves as Director of Research for the Division, with a clinical research profile focused on examining contemporary practice patterns and outcomes from endovascular and open surgical interventions.A Fellow of the American College of Surgeons, Dr. Stern is also an active member of the Society for Vascular Surgery, The Society for Clinical Vascular Surgery, The Western Vascular Society, and the Vascular and Endovascular Surgery Society where he serves in a leadership role on the Executive Council as Councilor-At-Large.
Scott T. Tagawa, M.D., MS, FACP, FASCO
Internal medicine practitioners

Scott T. Tagawa, M.D., MS, FACP, FASCO

Scott T. Tagawa, MD, MS, FACP, FASCO, is a Professor of Medicine and Urology at Weill Cornell Medicine, and an Attending Physician at NewYork-Presbyterian – Weill Cornell Medical Center. After earning his BS from Georgetown University, Dr. Tagawa received his Medical Degree at the University of Southern California (USC) School of Medicine. After completing his Internship and Residency training at USC, he became Chief Resident and subsequently underwent fellowship training in Hematology and Medical Oncology, being appointed Chief Fellow for his final two years. Dr. Tagawa had the opportunity to train with international leaders in Genitourinary (GU) Oncology. In August 2005, he was appointed Assistant Professor of Medicine at Mount Sinai School of Medicine, serving as Associate Program Director for the Fellowship Training Program. As Director of Genitourinary (GU) Oncology for the Division of Hematology and Oncology and Director of Medical Oncology for the Deane Prostate Health and Research Center, Dr. Tagawa took the lead in developing genitourinary clinical trials. He was recruited to Weill Cornell Medicine (WCM) in 2007. His research covers clinical and translational investigations in genitourinary tumors and thrombosis (blood clotting) in people with cancer. As the Medical Director of the Genitourinary Oncology Research Program, Dr. Tagawa leads clinical trials in the areas of prostate, kidney, and bladder cancer as well as the prevention and treatment of thrombosis with cancer. He specializes in drug development and theranostics in prostate cancer. Dr. Tagawa also serves as leader of the GU Disease Management Team and co-leader of the Experimental Therapeutics Program of the Meyer Cancer Center. He is the WCM principal investigator for the Alliance for Clinical Trials in Oncology (formerly CALGB), serving on the Board of Directors and as a funded member of the Genitourinary Committee. Additionally, he serves on the editorial boards of many journals, is a member of numerous national and international medical and scientific societies, and has been named on multiple “top doctor” award lists.EDUCATION/TRAINING:Georgetown University, Washington D.C. B.S.; 1993.University of Southern California School of Medicine, Los Angeles, CA. M.D.; 1998.Internship, Internal Medicine. University of Southern California Department of Medicine; June 1998 - June 1999.Residency, Internal Medicine. University of Southern California Department of Medicine; July 1999 - June 2001.Chief Resident, University of Southern California Department of Medicine, Los Angeles, CA.; July 2001 -June 2002.Fellowship, Combined program in Hematology and Oncology. University of Southern California Department of Medicine, Divisions of Hematology and Oncology; July 2002 - June 2005.Chief Fellow, Hematology; 2003-04.Chief Fellow, Oncology; 2004-05.Weill Cornell Graduate School of Medical Sciences, Masters of Science in Clinical Investigation; 2010.
United StatesNew YorkNew YorkRoger Hartl, M.D.

Yext